Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Journal of the American Heart Association
|
July 31, 2024
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
JACC. Cardiooncology
|
June 17, 2026
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants
Tomoyuki Nagai, Naohiko Nakanishi, Yugo Yamashita, et al.
Journal of Intensive Care
|
November 4, 2024
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2
Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
September 28, 2025
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants - Insights From the COMMAND VTE Registry-2
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 26, 2025
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2
Tatsunori Noto, Nobutaka Ikeda, Yugo Yamashita, et al.
Thrombosis and Haemostasis
|
April 29, 2024
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2
Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Thrombolysis
|
May 28, 2025
Edoxaban treatment without initial heparin lead-in for acute venous thromboembolism: insight from the COMMAND VTE registry-2
Yuta Tsujisaka, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
July 2, 2025
Prediction Score for Major Bleeding in Patients With Venous Thromboembolism Receiving Direct Oral Anticoagulants - Insights From the COMMAND VTE Registry-2
Satoshi Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 5, 2024
Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2
Toru Sato, Yoshito Ogihara, Yugo Yamashita, et al.
Journal of Thrombosis and Thrombolysis
|
May 18, 2024
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2
Hiroshi Mabuchi, Ryusuke Nishikawa, Yugo Yamashita, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Journal of the American Heart Association
|
July 31, 2024
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
JACC. Cardiooncology
|
June 17, 2026
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants
Tomoyuki Nagai, Naohiko Nakanishi, Yugo Yamashita, et al.
Journal of Intensive Care
|
November 4, 2024
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2
Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
September 28, 2025
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants - Insights From the COMMAND VTE Registry-2
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 26, 2025
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2
Tatsunori Noto, Nobutaka Ikeda, Yugo Yamashita, et al.
Thrombosis and Haemostasis
|
April 29, 2024
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2
Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Thrombolysis
|
May 28, 2025
Edoxaban treatment without initial heparin lead-in for acute venous thromboembolism: insight from the COMMAND VTE registry-2
Yuta Tsujisaka, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
July 2, 2025
Prediction Score for Major Bleeding in Patients With Venous Thromboembolism Receiving Direct Oral Anticoagulants - Insights From the COMMAND VTE Registry-2
Satoshi Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 5, 2024
Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2
Toru Sato, Yoshito Ogihara, Yugo Yamashita, et al.
Journal of Thrombosis and Thrombolysis
|
May 18, 2024
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2
Hiroshi Mabuchi, Ryusuke Nishikawa, Yugo Yamashita, et al.
Page
of 6